Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · July 10, 2023

Outcomes of Patients With Hemiretinal Vein Occlusion Treated With VEGF Inhibitors

The British Journal of Ophthalmology


Additional Info

The British Journal of Ophthalmology
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Br J Ophthalmol 2023 Jun 01;107(6)842-848, AR Hunt, V Nguyen, JJ Arnold, IL McAllister, H Mehta, A Invernizzi, T Ponsioen, PH Gabrielle, L O'Toole, P Kusenda, S Alforja, D Barthelmes, MC Gillies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading